Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000912057-00-039985
Filing Date
2000-09-01
Accepted
2000-09-01 00:00:00
Documents
12
Period of Report
2000-06-30

Document Format Files

Seq Description Document Type Size
1 10-K a10-k.txt 10-K 184555
2 EXHIBIT 10.1 ex-10_1.txt EX-10.1 59693
3 EXHIBIT 10.2 ex-10_2.txt EX-10.2 24740
4 EXHIBIT 10.3 ex-10_3.txt EX-10.3 43379
5 EXHIBIT 10.4 ex-10_4.txt EX-10.4 42843
6 EXHIBIT 10.5 ex-10_5.txt EX-10.5 176922
7 EXHIBIT 10.6 ex-10_6.txt EX-10.6 80455
8 EXHIBIT 10.7 ex-10_7.txt EX-10.7 65932
9 EXHIBIT 10.8 ex-10_8.txt EX-10.8 33059
10 EXHIBIT 21 ex-21.txt EX-21 404
11 EXHIBIT 23.1 ex-23_1.txt EX-23.1 607
12 EXHIBIT 27 a2020403zex-27.txt EX-27 2212
  Complete submission text file 0000912057-00-039985.txt   717824
Mailing Address 617 LUSK BLVD SAN DIEGO CA 92121
Business Address 6175 LUSK BLVD SAN DIEGO CA 92121 8584105200
ALLIANCE PHARMACEUTICAL CORP (Filer) CIK: 0000736994 (see all company filings)

EIN.: 141644018 | State of Incorp.: NY | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-12950 | Film No.: 715935
SIC: 2835 In Vitro & In Vivo Diagnostic Substances